Health Condition 1: M478- Other spondylosis
Conditions
Interventions
Intervention1: Homoeopathic medicine add on with yoga: Homoeopathic medicines as detailed in the standard Homoeopathic Materia Medica
and in the Homoeopathic Pharmacopoeia (India/US) will be used in t
Sponsors
Director General, Central Council for Research in Homoeopathy
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age between 30 to 70 years. 2. Both male and female patients. 3. Participants with chronic low back pain due to lumbar spondylosis (M47.8) of more than 3 months duration. 4. Participants with a radiological diagnosis of lumbar spondylosis with mild to moderate degenerative radiological changes. 5. A pain intensity of 5 or higher on a numerical rating scale of 0 to 10 is required for enrollment. 6. Washout phase of conventional or other medications for lumbar spondylosis, if any of, 2 weeks prior to enrollment. 7. Participants who are willing to give informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Participants with severe degenerative changes as found radiologically and those with major spinal disorders associated with LS. 2. Low back pain with systemic disorders (i.e., Primary joint disease such as active rheumatoid arthritis; Metabolic bone disease; Malignant bone disease; Uncontrolled DM and HTN, Cardiovascular, CKD and other severe illness, not able to consultation) 3. Pregnancy or lactation 4. Critically patients requiring orthopedic corrections 5. Substance abuse, alcoholism 6. Psychologically unstable patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Bournemouth questionnaire (BQ) score for painTimepoint: Baseline and every month up to 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Measurement of back-related disability through Modified Oswestry disability questionnaire (MODQ) for Indian populationTimepoint: Baseline and every month up to 3 months;Modified Naranjo Criteria for Homeopathy (MONARCH) may be taken as secondary outcome for evaluating the causal attribution between the given intervention and the clinical improvement at the end of treatment.Timepoint: At the end of study i.e., after 3 months of study | — |
Countries
India
Contacts
Public ContactDr Laijun Nahar
Central Council for Research in Homoeopathy
Outcome results
None listed